Literature DB >> 18500342

Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy.

Sandeep Uppal1, Christine P Diggle, Ian M Carr, Colin W G Fishwick, Mushtaq Ahmed, Gamal H Ibrahim, Philip S Helliwell, Anna Latos-Bieleńska, Simon E V Phillips, Alexander F Markham, Christopher P Bennett, David T Bonthron.   

Abstract

Digital clubbing, recognized by Hippocrates in the fifth century BC, is the outward hallmark of pulmonary hypertrophic osteoarthropathy, a clinical constellation that develops secondary to various acquired diseases, especially intrathoracic neoplasm. The pathogenesis of clubbing and hypertrophic osteoarthropathy has hitherto been poorly understood, but a clinically indistinguishable primary (idiopathic) form of hypertrophic osteoarthropathy (PHO) is recognized. This familial disorder can cause diagnostic confusion, as well as significant disability. By autozygosity methods, we mapped PHO to chromosome 4q33-q34 and identified mutations in HPGD, encoding 15-hydroxyprostaglandin dehydrogenase, the main enzyme of prostaglandin degradation. Homozygous individuals develop PHO secondary to chronically elevated prostaglandin E(2) levels. Heterozygous relatives also show milder biochemical and clinical manifestations. These findings not only suggest therapies for PHO, but also imply that clubbing secondary to other pathologies may be prostaglandin mediated. Testing for HPGD mutations and biochemical testing for HPGD deficiency in patients with unexplained clubbing might help to obviate extensive searches for occult pathology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18500342     DOI: 10.1038/ng.153

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  70 in total

1.  The diagnosis of art: WH Auden’s face.

Authors:  Jeffrey K Aronson; Manoj Ramachandran
Journal:  J R Soc Med       Date:  2011-01       Impact factor: 5.344

2.  Homozygous mutations in the 15-hydroxyprostaglandin dehydrogenase gene in patients with primary hypertrophic osteoarthropathy.

Authors:  Berrin Yüksel-Konuk; Aslı Sırmacı; Gülen Ece Ayten; Mustafa Özdemir; İdil Aslan; Ülkü Yılmaz-Turay; Yurdanur Erdoğan; Mustafa Tekin
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 2.631

3.  Significant increase of prostaglandin E-major urinary metabolite in male smokers: a screening study of age and gender differences using a simple radioimmunoassay.

Authors:  Isao Okayasu; Hiromitsu Ohnishi; Istvan Sarandi; Junko Shojima; Junko Komatsu; Masae Oritsu; Masataka Sasabe; Kaori Okayasu Nanami; Masaaki Matsuura; Jun-Ichi Azumi; Satoru Ito; Mutsunori Fujiwara
Journal:  J Clin Lab Anal       Date:  2013-12-27       Impact factor: 2.352

4.  HPGD mutations cause cranioosteoarthropathy but not autosomal dominant digital clubbing.

Authors:  Wenke Seifert; Julia Beninde; Katrin Hoffmann; Tom H Lindner; Christian Bassir; Fuat Aksu; Christoph Hübner; Nienke E Verbeek; Stefan Mundlos; Denise Horn
Journal:  Eur J Hum Genet       Date:  2009-07-01       Impact factor: 4.246

Review 5.  [Hypertrophic osteoarthropathy. Bamberger-Marie disease].

Authors:  B Manger; A Lindner; K Manger; J Wacker; G Schett
Journal:  Z Rheumatol       Date:  2011-09       Impact factor: 1.372

6.  Celecoxib treatment of fibrous dysplasia (FD) in a human FD cell line and FD-like lesions in mice with protein kinase A (PKA) defects.

Authors:  Emmanouil Saloustros; Sisi Liu; Edward L Mertz; Nisan Bhattacharyya; Matthew F Starost; Paraskevi Salpea; Maria Nesterova; Michael Collins; Sergey Leikin; Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2016-08-04       Impact factor: 4.102

Review 7.  Roles of Organic Anion Transporting Polypeptide 2A1 (OATP2A1/SLCO2A1) in Regulating the Pathophysiological Actions of Prostaglandins.

Authors:  Takeo Nakanishi; Ikumi Tamai
Journal:  AAPS J       Date:  2017-12-04       Impact factor: 4.009

8.  Circulating osteogenic cells: characterization and relationship to rates of bone loss in postmenopausal women.

Authors:  Anita Undale; Bhuma Srinivasan; Matthew Drake; Louise McCready; Elizabeth Atkinson; James Peterson; B Lawrence Riggs; Shreyasee Amin; U I Modder; U I Moedder; Sundeep Khosla
Journal:  Bone       Date:  2010-03-31       Impact factor: 4.398

9.  Primary hypertrophic osteoarthropathy caused by homozygous deletion in HPGD gene in a family: changing clinical and radiological findings with long-term follow-up.

Authors:  Beyhan Tüysüz; Saliha Yılmaz; Özgür Kasapçopur; Tuğba Erener-Ercan; Emre Ceyhun; Kaya Bilguvar; Murat Günel
Journal:  Rheumatol Int       Date:  2014-05-12       Impact factor: 2.631

10.  Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis syndrome is caused by a POC1A mutation.

Authors:  Ofer Sarig; Sagi Nahum; Debora Rapaport; Akemi Ishida-Yamamoto; Dana Fuchs-Telem; Li Qiaoli; Ksenya Cohen-Katsenelson; Ronen Spiegel; Janna Nousbeck; Shirli Israeli; Zvi-Uri Borochowitz; Gilly Padalon-Brauch; Jouni Uitto; Mia Horowitz; Stavit Shalev; Eli Sprecher
Journal:  Am J Hum Genet       Date:  2012-07-26       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.